awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08
Q48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
P2860
Q48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-7F66B64E-744A-49DC-8F99-FA12EF968E08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b7cb61de7553ee9966e59118dcc24aa74c3c217
P2860
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.